| Name | Title | Contact Details |
|---|
Premise Health is here to change the way people see and experience healthcare. We help organizations take healthcare farther – by bringing it closer than ever. We’ve created a worksite health model that achieves better patient engagement, and delivers higher-value programs that sustainably improve health outcomes to worksite and distributed workforces. For employers, this means finally controlling costs – while delivering a leading-edge health benefit that actually benefits health. On behalf of 220+ clients, Premise Health operates over 500 onsite health centers, pharmacies, and fitness centers in 46 states and 2 U.S. territories.
GetWellNetwork, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethesda, MD. To find more information about GetWellNetwork, Inc., please visit www.getwellnetwork.com
Tracy Anderson is the leader of the health and wellness industry and Creator of the Tracy Anderson Method, offering fitness DVDs, online workouts, state-of-the-art exercise studios, nutritional products, apparel and more.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
DAKO is a fully integrated, global provider of cancer diagnostic and research products for pathology and oncology. The Company's products utilize antibodies, nucleic acid probes, and proprietary detection technologies to identify specific